We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$183M
AUM Growth
+$3.53M
Cap. Flow
-$2.05M
Cap. Flow %
-1.12%
Top 10 Hldgs %
43.27%
Holding
232
New
9
Increased
24
Reduced
46
Closed
37

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$3.03M
2
GS icon
Goldman Sachs
GS
+$1.64M
3
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$906K
4
CMCSA icon
Comcast
CMCSA
+$574K
5
GDX icon
VanEck Gold Miners ETF
GDX
+$466K

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$3.38M
2
AGN
Allergan plc
AGN
+$1.6M
3
RRC icon
Range Resources
RRC
+$1.3M
4
SLB icon
SLB Ltd
SLB
+$460K
5
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
+$314K

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Energy 14.97%
3 Financials 14.94%
4 Healthcare 11.14%
5 Communication Services 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DGAZ
176
DELISTED
VelocityShares 3x Inverse Natural Gas ETN linked to the S&P GSCI Natural Gas Index Excess Return
DGAZ
$5K ﹤0.01%
+11
New +$5.57K
IEO icon
177
iShares US Oil & Gas Exploration & Production ETF
IEO
$580M
$4K ﹤0.01%
+54
New +$3.86K
INO icon
178
Inovio Pharmaceuticals
INO
$55.7M
$4K ﹤0.01%
83
– –
IONS icon
179
Ionis Pharmaceuticals
IONS
$8.6B
$4K ﹤0.01%
90
– –
NFG icon
180
National Fuel Gas
NFG
$7.82B
$4K ﹤0.01%
70
– –
QGEN icon
181
Qiagen
QGEN
$8.54B
$4K ﹤0.01%
112
– –
MNDT
182
DELISTED
Mandiant, Inc. Common Stock
MNDT
$4K ﹤0.01%
250
– –
GM.WS.B
183
DELISTED
General Motors Company
GM.WS.B
$4K ﹤0.01%
+198
New +$4.3K
TTNP
184
DELISTED
Titan Pharmaceuticals
TTNP
$3K ﹤0.01%
1
– –
YUM icon
185
Yum! Brands
YUM
$41.8B
$3K ﹤0.01%
40
– –
YINN icon
186
Direxion Daily FTSE China Bull 3X ETF
YINN
$782M
$2K ﹤0.01%
+4
New +$2.6K
YUMC icon
187
Yum China
YUMC
$16.5B
$2K ﹤0.01%
40
– –
C icon
188
Citigroup
C
$222B
$1K ﹤0.01%
13
– –
JRS icon
189
Nuveen Real Estate Income Fund
JRS
$250M
$1K ﹤0.01%
150
– –
ABT icon
190
Abbott
ABT
$183B
– –
-119
Closed -$7K
AR icon
191
Antero Resources
AR
$11.1B
– –
-3,150
Closed -$62K
ASIX icon
192
AdvanSix
ASIX
$541M
– –
-27
Closed –
AVGO icon
193
Broadcom
AVGO
$1.85T
– –
-3,400
Closed -$80K
BBWI icon
194
Bath & Body Works
BBWI
$4.06B
– –
-155
Closed -$4K
BF.B icon
195
Brown-Forman Class B
BF.B
$13.2B
– –
-27
Closed -$1K
BF.A icon
196
Brown-Forman Class A
BF.A
$13.4B
– –
-110
Closed -$5K
BHF icon
197
Brighthouse Financial
BHF
$3.56B
– –
-72
Closed -$3K
BKD icon
198
Brookdale Senior Living
BKD
$3.49B
– –
-500
Closed -$3K
BSX icon
199
Boston Scientific
BSX
$69.5B
– –
-100
Closed -$2K
DEO icon
200
Diageo
DEO
$49B
– –
-105
Closed -$14K
6 7
8
9 10

Similar funds

HCP
Hexagon Capital Partners Rogers, Arkansas $683M AUM 34.85% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $685M AUM 15.32% 1-Year Est. Return
HWM
Horizon Wealth Management La Grange, Illinois $682M AUM 25.04% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
DMC
Drexel Morgan & Co Radnor, Pennsylvania $682M AUM 21.01% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return

Blume Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Blume Capital Management held 232 positions worth $183M, up 2% from $180M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Blume Capital Management's Q2 2018 filing shows 9 new, 24 increased, 46 reduced and 37 closed positions. Its largest new stake was CVS Health: 46,045 shares worth $2.96M. The largest sale was TJX Companies, an estimated $3.38M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Energy and Financials.

  • Blume Capital Management's largest Q2 2018 buy was CVS Health: 46,045 shares worth $2.96M.
  • Blume Capital Management added most to Goldman Sachs in Q2 2018, an estimated $1.64M increase.
  • Blume Capital Management's biggest Q2 2018 reduction was TJX Companies, cutting an estimated $3.38M.
  • Blume Capital Management fully exited Range Resources in Q2 2018, selling an estimated $1.3M.
  • Blume Capital Management's ten largest holdings make up 43% of its $183M portfolio in Q2 2018.
  • Blume Capital Management opened 9 new positions and closed 37 in Q2 2018.
  • Blume Capital Management's portfolio value rose 2% quarter-over-quarter to $183M.

Based on Blume Capital Management's 13F filing for Q2 2018, filed 2 Aug 2018.